These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 14634491)

  • 1. I. Veterans Affairs Cooperative Study of polyenylphosphatidylcholine in alcoholic liver disease: effects on drinking behavior by nurse/physician teams.
    Lieber CS; Weiss DG; Groszmann R; Paronetto F; Schenker S;
    Alcohol Clin Exp Res; 2003 Nov; 27(11):1757-64. PubMed ID: 14634491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. II. Veterans Affairs Cooperative Study of polyenylphosphatidylcholine in alcoholic liver disease.
    Lieber CS; Weiss DG; Groszmann R; Paronetto F; Schenker S;
    Alcohol Clin Exp Res; 2003 Nov; 27(11):1765-72. PubMed ID: 14634492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brief physician advice for problem drinkers: long-term efficacy and benefit-cost analysis.
    Fleming MF; Mundt MP; French MT; Manwell LB; Stauffacher EA; Barry KL
    Alcohol Clin Exp Res; 2002 Jan; 26(1):36-43. PubMed ID: 11821652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study.
    Salloum IM; Cornelius JR; Daley DC; Kirisci L; Himmelhoch JM; Thase ME
    Arch Gen Psychiatry; 2005 Jan; 62(1):37-45. PubMed ID: 15630071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pilot double-blind treatment trial of memantine for alcohol dependence.
    Evans SM; Levin FR; Brooks DJ; Garawi F
    Alcohol Clin Exp Res; 2007 May; 31(5):775-82. PubMed ID: 17378918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reducing alcohol consumption. Comparing three brief methods in family practice.
    McIntosh MC; Leigh G; Baldwin NJ; Marmulak J
    Can Fam Physician; 1997 Nov; 43():1959-62, 1965-7. PubMed ID: 9386883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Motivational interviewing with hazardous drinkers.
    Beckham N
    J Am Acad Nurse Pract; 2007 Feb; 19(2):103-10. PubMed ID: 17300536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of fibrosis markers for staging liver fibrosis in patients with precirrhotic alcoholic liver disease.
    Lieber CS; Weiss DG; Paronetto F;
    Alcohol Clin Exp Res; 2008 Jun; 32(6):1031-9. PubMed ID: 18422837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alcohol consumption is associated with progression of hepatic fibrosis in non-alcoholic fatty liver disease.
    Ekstedt M; Franzén LE; Holmqvist M; Bendtsen P; Mathiesen UL; Bodemar G; Kechagias S
    Scand J Gastroenterol; 2009; 44(3):366-74. PubMed ID: 19016382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can recovering alcoholics help hospitalized patients with alcohol problems?
    Blondell RD; Looney SW; Northington AP; Lasch ME; Rhodes SB; McDaniels RL
    J Fam Pract; 2001 May; 50(5):447. PubMed ID: 11350721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating readiness and treatment seeking effects in a pharmacotherapy trial for alcohol dependence.
    Penberthy JK; Ait-Daoud N; Breton M; Kovatchev B; DiClemente CC; Johnson BA
    Alcohol Clin Exp Res; 2007 Sep; 31(9):1538-44. PubMed ID: 17624996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Web-based screening and brief intervention for hazardous drinking: a double-blind randomized controlled trial.
    Kypri K; Saunders JB; Williams SM; McGee RO; Langley JD; Cashell-Smith ML; Gallagher SJ
    Addiction; 2004 Nov; 99(11):1410-7. PubMed ID: 15500594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted nalmefene with simple medical management in the treatment of heavy drinkers: a randomized double-blind placebo-controlled multicenter study.
    Karhuvaara S; Simojoki K; Virta A; Rosberg M; Löyttyniemi E; Nurminen T; Kallio A; Mäkelä R
    Alcohol Clin Exp Res; 2007 Jul; 31(7):1179-87. PubMed ID: 17451401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opportunistic screening and clinician-delivered brief intervention for high-risk alcohol use among emergency department attendees: a randomized controlled trial.
    Dent AW; Weiland TJ; Phillips GA; Lee NK
    Emerg Med Australas; 2008 Apr; 20(2):121-8. PubMed ID: 18377401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized-controlled trial of a telephone and mail intervention for alcohol use disorders: three-month drinking outcomes.
    Brown RL; Saunders LA; Bobula JA; Mundt MP; Koch PE
    Alcohol Clin Exp Res; 2007 Aug; 31(8):1372-9. PubMed ID: 17550366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted naltrexone for early problem drinkers.
    Kranzler HR; Armeli S; Tennen H; Blomqvist O; Oncken C; Petry N; Feinn R
    J Clin Psychopharmacol; 2003 Jun; 23(3):294-304. PubMed ID: 12826991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening and brief intervention targeting risky drinkers in Danish general practice--a pragmatic controlled trial.
    Beich A; Gannik D; Saelan H; Thorsen T
    Alcohol Alcohol; 2007; 42(6):593-603. PubMed ID: 17855332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of liver biopsy on abstinence in alcohol-dependent patients.
    Trabut JB; Plat A; Thepot V; Fontaine H; Vallet-Pichard A; Nalpas B; Pol S
    Alcohol Alcohol; 2008; 43(5):559-63. PubMed ID: 18621800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Palmitoyl-catechin for alcoholic liver disease: results of a three-month clinical trial.
    World MJ; Ryle PR; Aps EJ; Shaw GK; Thomson AD
    Alcohol Alcohol; 1987; 22(4):331-40. PubMed ID: 3322310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term treatment of alcoholic liver disease with propylthiouracil.
    Orrego H; Blake JE; Blendis LM; Compton KV; Israel Y
    N Engl J Med; 1987 Dec; 317(23):1421-7. PubMed ID: 3317042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.